| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 271 | 2018 |
| CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial DM Smith, KW Weitzel, AR Elsey, T Langaee, Y Gong, DT Wake, ... Genetics in Medicine 21 (8), 1842-1850, 2019 | 139 | 2019 |
| Experimental comparison of a germanium avalanche photodiode and InGaAs PINFET receiver for longer wavelength optical communication systems DR Smith, RC Hooper, PP Smyth, D Wake Electronics Letters 11 (18), 453-454, 1982 | 76 | 1982 |
| Pharmacogenomics: prescribing precisely DT Wake, N Ilbawi, HM Dunnenberger, PJ Hulick Medical Clinics 103 (6), 977-990, 2019 | 65 | 2019 |
| Primary care physician experiences with integrated pharmacogenomic testing in a community health system AA Lemke, CG Hutten Selkirk, NS Glaser, AW Sereika, DT Wake, ... Personalized medicine 14 (5), 389-400, 2017 | 56 | 2017 |
| Patient perspectives following pharmacogenomics results disclosure in an integrated health system AA Lemke, PJ Hulick, DT Wake, C Wang, AW Sereika, KD Yu, NS Glaser, ... Pharmacogenomics 19 (4), 321-331, 2018 | 45 | 2018 |
| pi-nf. et hybrid optical receiver for 1.1? 1.6? m optical communication systems DR Smith, AK Chatterjee, MAZ Rejman, D Wake, BR White Electronics Letters 19 (16), 750-751, 1980 | 40 | 1980 |
| Implementation of standardized clinical processes for TPMT testing in a diverse multidisciplinary population: challenges and lessons learned KW Weitzel, DM Smith, AR Elsey, BQ Duong, B Burkley, M Clare‐Salzler, ... Clinical and translational science 11 (2), 175-181, 2018 | 35 | 2018 |
| Pharmacogenomic clinical decision support: a review, how‐to guide, and future vision DT Wake, DM Smith, S Kazi, HM Dunnenberger Clinical Pharmacology & Therapeutics 112 (1), 44-57, 2022 | 34 | 2022 |
| Prospective clinical implementation of CYP2C19-genotype guided antiplatelet therapy after PCI: a multi-site investigation of MACE outcomes in a real-world setting LH Cavallari, JC Denny, CR Lee, AL Beitelshees, JD Duarte, SE Kimmel, ... Circulation 134 (25), E711-E712, 2016 | 13 | 2016 |
| Pharmacogenomic clinical decision support: a scoping review DM Smith, DT Wake, HM Dunnenberger Clinical Pharmacology & Therapeutics 113 (4), 803-815, 2023 | 10 | 2023 |
| Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparison DT Wake, GC Bell, DB Gregornik, TT Ho, HM Dunnenberger Pharmacogenomics 22 (3), 165-176, 2021 | 9 | 2021 |
| Flype: Software for enabling personalized medicine DL Helseth Jr, K Gulukota, N Miller, M Yang, T Werth, LM Sabatini, ... American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2021 | 6 | 2021 |
| Personalized medicine in a community health system: The NorthShore experience SP David, HM Dunnenberger, S Choi, A DePersia, N Ilbawi, C Ward, ... Frontiers in Genetics 14, 1308738, 2023 | 2 | 2023 |
| A clinician’s guide for counseling patients on results of a multigene pharmacogenomic panel TT Ho, G Bell, RS Gammal, D Gregornik, DT Wake, HM Dunnenberger American Journal of Health-System Pharmacy 79 (19), 1634-1644, 2022 | 2 | 2022 |
| Effect modification by social determinants of pharmacogenetic medication interactions on 90-day hospital readmissions within an integrated US Healthcare system L Saulsberry, L Singh, J Pruitt, C Ward, DT Wake, RD Gibbons, ... Journal of Personalized Medicine 12 (7), 1145, 2022 | 1 | 2022 |
| Pharmacogenomic Testing and Somatic Next-Generation Sequencing of Patients with Advanced Solid Tumors M Bouma, D Wake, G Moorthy, A Serieka, L Ochs, H Dunnenberger, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S90-S90, 2023 | | 2023 |
| Pharmacogenomics of medications given via nonconventional administration routes: a scoping review S Socco, DT Wake, JC Lee, HM Dunnenberger Pharmacogenomics 23 (17), 933-948, 2022 | | 2022 |
| PREVALENCE OF ACTIONABLE GENOTYPES AND DRUG EXPOSURE AMONG PATIENTS UNDERGOING CARDIAC CATHETERIZATION IN THE UNIVERSITY OF FLORIDA PERSONALIZED MEDICINE PROGRAM. N El Rouby, S Mosley, D Wake, X Liu, KW Weitzel, AR Elsey, A Riva, ... Clinical Pharmacology & Therapeutics 103, S31-S31, 2018 | | 2018 |
| OUTPATIENT CYP2D6 GENOTYPE-SUPPORTED OPIOID THERAPY: A PROSPECTIVE TRIAL. DM Smith, KW Weitzel, AR Elsey, DT Wake, Y Gong, BQ Duong, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 103, S8-S8, 2018 | | 2018 |
